These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
139 related items for PubMed ID: 6968175
1. Metronidazole in treatment against Haemophilus vaginalis (Corynebacterium vaginale). Ralph ED, Amatnieks YE. Antimicrob Agents Chemother; 1980 Jul; 18(1):101-4. PubMed ID: 6968175 [Abstract] [Full Text] [Related]
2. Comparative antimicrobial activity of metronidazole and the hydroxy metabolite against Gardnerella vaginalis. Ralph ED. Scand J Infect Dis Suppl; 1983 Jul; 40():115-20. PubMed ID: 6607518 [Abstract] [Full Text] [Related]
3. Inhibition of Haemophilus vaginalis (Corynebacterium vaginale) by metronidazole, tetracycline, and ampicillin. Ralph ED, Austin TW, Pattison FL, Schieven BC. Sex Transm Dis; 1979 Jul; 6(3):199-202. PubMed ID: 388682 [Abstract] [Full Text] [Related]
4. Metronidazole metabolite and Gardnerella vaginalis (Corynebacterium vaginale). Baldson MJ, Jackson D. Lancet; 1981 May 16; 1(8229):1112. PubMed ID: 6112482 [No Abstract] [Full Text] [Related]
6. Relative susceptibilities of Gardnerella vaginalis (Haemophilus vaginalis), Neisseria gonorrhoeae, and Bacteroides fragilis to Metronidazole and its two major metabolites. Ralph ED, Amatnieks YE. Sex Transm Dis; 1980 May 16; 7(4):157-60. PubMed ID: 6779387 [Abstract] [Full Text] [Related]
7. Susceptibility of Gardnerella vaginalis to metronidazole, its bioactive metabolites, and tinidazole. Bannatyne RM, Jackowski J, Cheung R, Biers K. Am J Clin Pathol; 1987 May 16; 87(5):640-1. PubMed ID: 3495168 [Abstract] [Full Text] [Related]
8. Sensitivity of Haemophilus vaginalis (Corynebacterium vaginale) to oleandomycin and spectinomycin. Virtanen S. Pathol Microbiol (Basel); 1975 May 16; 42(1):36-41. PubMed ID: 125402 [Abstract] [Full Text] [Related]
9. Antibiotic susceptibility of Haemophilus vaginalis (Corynebacterium vaginale) to 21 antibiotics. McCarthy LR, Mickelsen PA, Smith EG. Antimicrob Agents Chemother; 1979 Aug 16; 16(2):186-9. PubMed ID: 314776 [Abstract] [Full Text] [Related]
10. Susceptibility of Gardnerella vaginalis to thiamphenicol: clinical experience with nonspecific vaginitis. Hubrechts JM, Vanhoof RL, Daems A, Butzler JP. Sex Transm Dis; 1984 Aug 16; 11(4 Suppl):456-9. PubMed ID: 6335301 [Abstract] [Full Text] [Related]
11. [In vitro activity of 5 new quinolones against Gardnerella vaginalis]. Lefevre JC, Gaubert E, Lareng MB. Pathol Biol (Paris); 1989 May 16; 37(5):394-6. PubMed ID: 2550875 [Abstract] [Full Text] [Related]
15. Sensitivity of Gardnerella vaginalis to metabolites of metronidazole and tinidazole. Shanker S, Munro R. Lancet; 1982 Jan 16; 1(8264):167. PubMed ID: 6119542 [No Abstract] [Full Text] [Related]
16. Nonspecific vaginitis: role of Haemophilus vaginalis and treatment with metronidazole. Pheifer TA, Forsyth PS, Durfee MA, Pollock HM, Holmes KK. N Engl J Med; 1978 Jun 29; 298(26):1429-34. PubMed ID: 306577 [Abstract] [Full Text] [Related]
17. In vitro susceptibility of Gardnerella vaginalis and Bacteroides organisms, associated with nonspecific vaginitis, to sulfonamide preparations. Jones BM, Kinghorn GR, Geary I. Antimicrob Agents Chemother; 1982 Jun 29; 21(6):870-2. PubMed ID: 6981374 [Abstract] [Full Text] [Related]
18. In-vitro and in-vivo activity of metronidazole against Gardnerella vaginalis, Bacteroides spp. and Mobiluncus spp. in bacterial vaginosis. Jones BM, Geary I, Alawattegama AB, Kinghorn GR, Duerden BI. J Antimicrob Chemother; 1985 Aug 29; 16(2):189-97. PubMed ID: 3905748 [Abstract] [Full Text] [Related]
19. Factors affecting isolation and identification of Haemophilus vaginalis (Corynebacterium vaginale). Bailey RK, Voss JL, Smith RF. J Clin Microbiol; 1979 Jan 29; 9(1):65-71. PubMed ID: 372217 [Abstract] [Full Text] [Related]